<!DOCTYPE html>
<html lang="en">
<head>
  <meta charset="UTF-8">
  <meta name="viewport" content="width=device-width, initial-scale=1.0">
  <title>Neurodegenerative & Movement Disorders - Domain 7: Biopsychology | MasteryPage</title>
  <link href="https://fonts.googleapis.com/css2?family=Inter:wght@300;400;500;600;700&family=Instrument+Serif:ital@0;1&display=swap" rel="stylesheet">
  <style>
    :root { --bg-primary: #09090b; --bg-secondary: #0f0f11; --bg-tertiary: #18181b; --bg-card: #1c1c1f; --text-primary: #fafafa; --text-secondary: #a1a1aa; --text-muted: #71717a; --accent: #ec4899; --accent-dim: rgba(236, 72, 153, 0.15); --border: rgba(255, 255, 255, 0.06); --border-light: rgba(255, 255, 255, 0.1); --gradient-gold: linear-gradient(135deg, #f59e0b 0%, #d97706 100%); --success: #22c55e; --success-dim: rgba(34, 197, 94, 0.15); --blue: #3b82f6; --blue-dim: rgba(59, 130, 246, 0.15); --radius-sm: 8px; --radius-md: 12px; --radius-lg: 16px; --font-display: 'Instrument Serif', Georgia, serif; --font-body: 'Inter', -apple-system, sans-serif; }
    * { margin: 0; padding: 0; box-sizing: border-box; } body { font-family: var(--font-body); background: var(--bg-primary); color: var(--text-primary); line-height: 1.7; }
    .top-nav { position: fixed; top: 0; left: 0; right: 0; height: 72px; background: rgba(9, 9, 11, 0.95); backdrop-filter: blur(20px); border-bottom: 1px solid var(--border); z-index: 1000; display: flex; align-items: center; padding: 0 32px; }
    .nav-left { display: flex; align-items: center; gap: 24px; } .logo { display: flex; align-items: center; gap: 10px; text-decoration: none; } .logo-icon { width: 36px; height: 36px; background: var(--gradient-gold); border-radius: 10px; display: flex; align-items: center; justify-content: center; } .logo-icon svg { width: 20px; height: 20px; color: var(--bg-primary); } .logo-text { font-family: var(--font-display); font-size: 1.35rem; color: var(--text-primary); }
    .breadcrumb { display: flex; align-items: center; gap: 8px; font-size: 0.9rem; color: var(--text-muted); } .breadcrumb a { color: var(--text-secondary); text-decoration: none; } .breadcrumb a:hover { color: var(--accent); } .breadcrumb svg { width: 16px; height: 16px; }
    .content-wrapper { padding-top: 72px; display: flex; min-height: 100vh; } .sidebar { width: 280px; background: var(--bg-secondary); border-right: 1px solid var(--border); position: fixed; top: 72px; bottom: 0; overflow-y: auto; padding: 24px 0; } .sidebar-header { padding: 0 20px 16px; border-bottom: 1px solid var(--border); margin-bottom: 16px; } .sidebar-title { font-size: 0.75rem; text-transform: uppercase; letter-spacing: 0.1em; color: var(--text-muted); margin-bottom: 8px; } .domain-title { font-size: 1rem; font-weight: 600; color: var(--accent); }
    .chapter-list { list-style: none; } .chapter-item { border-bottom: 1px solid var(--border); } .chapter-link { display: flex; align-items: center; gap: 12px; padding: 14px 20px; color: var(--text-secondary); text-decoration: none; font-size: 0.85rem; transition: all 0.2s ease; } .chapter-link:hover { background: var(--bg-tertiary); color: var(--text-primary); } .chapter-link.active { background: var(--accent-dim); color: var(--accent); border-left: 3px solid var(--accent); } .chapter-number { width: 24px; height: 24px; border-radius: 50%; background: var(--bg-tertiary); display: flex; align-items: center; justify-content: center; font-size: 0.75rem; font-weight: 600; flex-shrink: 0; }
    .main-content { margin-left: 280px; flex: 1; padding: 48px 64px; max-width: 900px; } .chapter-header { margin-bottom: 48px; } .chapter-badge { display: inline-flex; align-items: center; gap: 8px; padding: 6px 12px; background: var(--bg-tertiary); border: 1px solid var(--border); border-radius: 20px; font-size: 0.8rem; color: var(--text-muted); margin-bottom: 16px; }
    h1 { font-family: var(--font-display); font-size: 2.5rem; margin-bottom: 16px; line-height: 1.2; } .chapter-meta { display: flex; gap: 24px; color: var(--text-muted); font-size: 0.9rem; } .content-section { margin-bottom: 48px; }
    h2 { font-family: var(--font-display); font-size: 1.75rem; margin: 48px 0 20px; padding-bottom: 12px; border-bottom: 1px solid var(--border); } h2:first-of-type { margin-top: 0; } h3 { font-size: 1.25rem; font-weight: 600; margin: 32px 0 16px; color: var(--text-primary); }
    p { margin-bottom: 16px; color: var(--text-secondary); } ul, ol { margin: 16px 0; padding-left: 24px; color: var(--text-secondary); } li { margin-bottom: 8px; }
    .key-term { background: var(--accent-dim); color: var(--accent); padding: 2px 8px; border-radius: 4px; font-weight: 500; }
    .definition-box { background: var(--bg-card); border: 1px solid var(--border); border-radius: var(--radius-md); padding: 20px; margin: 24px 0; } .definition-box strong { color: var(--accent); } .definition-box p:last-child { margin-bottom: 0; }
    .example-box { background: var(--blue-dim); border: 1px solid rgba(59, 130, 246, 0.3); border-radius: var(--radius-md); padding: 20px; margin: 24px 0; } .example-box strong { color: var(--blue); } .example-box p:last-child { margin-bottom: 0; }
    .clinical-note { background: var(--success-dim); border: 1px solid rgba(34, 197, 94, 0.3); border-radius: var(--radius-md); padding: 20px; margin: 24px 0; } .clinical-note strong { color: var(--success); } .clinical-note p:last-child { margin-bottom: 0; }
    .citation { font-size: 0.85rem; color: var(--text-muted); padding: 16px; background: var(--bg-tertiary); border-left: 3px solid var(--accent); margin: 16px 0; border-radius: 0 var(--radius-sm) var(--radius-sm) 0; }
    table { width: 100%; border-collapse: collapse; margin: 24px 0; } th, td { padding: 12px 16px; text-align: left; border: 1px solid var(--border); } th { background: var(--bg-tertiary); font-weight: 600; color: var(--text-primary); } td { color: var(--text-secondary); }
    .nav-buttons { display: flex; justify-content: space-between; margin-top: 64px; padding-top: 32px; border-top: 1px solid var(--border); } .nav-btn { display: flex; align-items: center; gap: 12px; padding: 16px 24px; background: var(--bg-card); border: 1px solid var(--border); border-radius: var(--radius-md); text-decoration: none; color: var(--text-secondary); transition: all 0.2s ease; } .nav-btn:hover { border-color: var(--accent); color: var(--text-primary); } .nav-btn-label { font-size: 0.8rem; color: var(--text-muted); } .nav-btn-title { font-weight: 600; color: var(--text-primary); }
    @media (max-width: 1024px) { .sidebar { display: none; } .main-content { margin-left: 0; padding: 32px 24px; } }
    .chapter-actions { display: flex; gap: 12px; margin-bottom: 32px; flex-wrap: wrap; } .action-btn { display: inline-flex; align-items: center; gap: 8px; padding: 10px 20px; border-radius: 8px; font-size: 0.85rem; font-weight: 500; text-decoration: none; transition: all 0.2s ease; }
    .flashcard-btn { background: var(--bg-tertiary); border: 1px solid var(--border-light); color: var(--text-secondary); } .flashcard-btn:hover { background: var(--bg-card); color: var(--text-primary); border-color: var(--accent); }
    .quiz-btn { background: var(--bg-tertiary); border: 1px solid var(--border-light); color: var(--text-secondary); } .quiz-btn:hover { background: var(--bg-card); color: var(--text-primary); border-color: var(--accent); }
    .mastery-btn { background: linear-gradient(135deg, #f59e0b 0%, #ef4444 100%); border: none; color: #fff; font-weight: 600; box-shadow: 0 2px 12px rgba(245, 158, 11, 0.3); } .mastery-btn:hover { box-shadow: 0 4px 20px rgba(245, 158, 11, 0.5); transform: translateY(-1px); }
    .upgrade-modal-overlay { display:none; position:fixed; top:0; left:0; right:0; bottom:0; background:rgba(0,0,0,0.7); z-index:1000; align-items:center; justify-content:center; } .upgrade-modal-overlay.visible { display:flex; } .upgrade-modal { background:var(--bg-card); border:1px solid var(--border); border-radius:var(--radius-lg); padding:40px; max-width:420px; width:90%; text-align:center; } .upgrade-modal-icon { width:64px; height:64px; margin:0 auto 20px; background:linear-gradient(135deg,#f59e0b 0%,#ef4444 100%); border-radius:50%; display:flex; align-items:center; justify-content:center; } .upgrade-modal-icon svg { color:#fff; } .upgrade-modal h3 { font-size:1.25rem; margin-bottom:8px; color:var(--text-primary); } .upgrade-modal p { color:var(--text-secondary); margin-bottom:24px; font-size:0.9rem; line-height:1.6; } .upgrade-modal-actions { display:flex; gap:12px; } .upgrade-modal-actions a, .upgrade-modal-actions button { flex:1; padding:12px; border-radius:8px; font-size:0.85rem; font-weight:600; cursor:pointer; text-decoration:none; text-align:center; border:none; } .upgrade-modal .btn-dismiss { background:var(--bg-tertiary); color:var(--text-secondary); border:1px solid var(--border); } .upgrade-modal .btn-upgrade { background:linear-gradient(135deg,#f59e0b 0%,#ef4444 100%); color:#fff; }
  </style>
</head>
<body>
  <nav class="top-nav"><div class="nav-left"><a href="/" class="logo"><div class="logo-icon"><svg viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2.5"><path d="M12 2L2 7l10 5 10-5-10-5z"/><path d="M2 17l10 5 10-5"/><path d="M2 12l10 5 10-5"/></svg></div><span class="logo-text">MasteryPage</span></a>
    <div class="breadcrumb"><svg viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2"><path d="M9 18l6-6-6-6"/></svg><a href="../../textbook.html">Textbook</a><svg viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2"><path d="M9 18l6-6-6-6"/></svg><a href="index.html">Domain 7</a><svg viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2"><path d="M9 18l6-6-6-6"/></svg><span>Neurodegenerative &amp; Movement Disorders</span></div></div></nav>
  <div class="content-wrapper">
    <aside class="sidebar"><div class="sidebar-header"><div class="sidebar-title">Domain 7</div><div class="domain-title">Biopsychology</div></div>
      <ul class="chapter-list">
        <li class="chapter-item"><a href="index.html" class="chapter-link"><span class="chapter-number">0</span>Overview</a></li>
        <li class="chapter-item"><a href="brain-structure-lateralization.html" class="chapter-link"><span class="chapter-number">1</span>Brain Structure &amp; Lateralization</a></li>
        <li class="chapter-item"><a href="learning-encoding.html" class="chapter-link"><span class="chapter-number">2</span>Learning Processes &amp; Encoding Strategies</a></li>
        <li class="chapter-item"><a href="memory-architecture.html" class="chapter-link"><span class="chapter-number">3</span>Memory Architecture &amp; Working Memory</a></li>
        <li class="chapter-item"><a href="retrieval-forgetting.html" class="chapter-link"><span class="chapter-number">4</span>Retrieval, Forgetting &amp; Memory Distortion</a></li>
        <li class="chapter-item"><a href="neuroscience-memory.html" class="chapter-link"><span class="chapter-number">5</span>Neuroscience of Memory &amp; Amnesia</a></li>
        <li class="chapter-item"><a href="sleep-architecture.html" class="chapter-link"><span class="chapter-number">6</span>Sleep Architecture, Dreaming &amp; the Lifespan</a></li>
        <li class="chapter-item"><a href="neurons-neurotransmitters.html" class="chapter-link"><span class="chapter-number">7</span>Neurons, Neurotransmitters &amp; Neural Signaling</a></li>
        <li class="chapter-item"><a href="emotion-arousal.html" class="chapter-link"><span class="chapter-number">8</span>Emotion Theories, Arousal &amp; the ANS</a></li>
        <li class="chapter-item"><a href="sensation-perception.html" class="chapter-link"><span class="chapter-number">9</span>Sensation, Perception &amp; Psychophysics</a></li>
        <li class="chapter-item"><a href="neurodegenerative-movement.html" class="chapter-link active"><span class="chapter-number">10</span>Neurodegenerative &amp; Movement Disorders</a></li>
        <li class="chapter-item"><a href="cerebrovascular-injury.html" class="chapter-link"><span class="chapter-number">11</span>Cerebrovascular Disease, Brain Injury &amp; Seizures</a></li>
        <li class="chapter-item"><a href="endocrine-neuroimaging.html" class="chapter-link"><span class="chapter-number">12</span>Endocrine Conditions, Neuroimaging &amp; Diagnostics</a></li>
        <li class="chapter-item"><a href="neurocognitive.html" class="chapter-link"><span class="chapter-number">13</span>Neurocognitive Disorders</a></li>
      </ul>
    </aside>
    <main class="main-content">
      <div class="chapter-header">
        <div class="chapter-badge">Chapter 10 of 13</div>
        <h1>Neurodegenerative &amp; Movement Disorders</h1>
        <div class="chapter-meta"><span>Domain 7: Biopsychology</span><span>~25 min read</span></div>
      </div>
      <div class="chapter-actions">
        <a href="javascript:void(0)" onclick="chapterAction('flashcards')" class="action-btn flashcard-btn"><svg width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2"><rect x="2" y="3" width="20" height="14" rx="2"/><line x1="8" y1="21" x2="16" y2="21"/><line x1="12" y1="17" x2="12" y2="21"/></svg>Flashcards</a>
        <a href="javascript:void(0)" onclick="chapterAction('quiz-fundamental', 7)" class="action-btn quiz-btn"><svg width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2"><path d="M9 11l3 3L22 4"/><path d="M21 12v7a2 2 0 01-2 2H5a2 2 0 01-2-2V5a2 2 0 012-2h11"/></svg>Quick Quiz: Fundamental</a>
        <a href="javascript:void(0)" onclick="chapterAction('advanced-learning', 7)" class="action-btn mastery-btn"><svg width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2"><polygon points="12 2 15.09 8.26 22 9.27 17 14.14 18.18 21.02 12 17.77 5.82 21.02 7 14.14 2 9.27 8.91 8.26 12 2"/></svg>Advanced Learning</a>
      </div>

      <div class="content-section">
        <h2>Parkinson's Disease</h2>
        <p><span class="key-term">Parkinson's disease (PD)</span> is a progressive neurodegenerative disorder caused by the loss of dopaminergic neurons in the <span class="key-term">substantia nigra pars compacta</span>, which projects to the striatum (caudate nucleus and putamen) via the nigrostriatal pathway. The result is a dramatic reduction in striatal dopamine, producing the characteristic motor symptoms.</p>
        <div class="definition-box">
          <strong>Cardinal Motor Features (TRAP):</strong>
          <p><span class="key-term">Tremor</span> (resting tremor, "pill-rolling," 4-6 Hz, decreases with voluntary movement); <span class="key-term">Rigidity</span> (cogwheel or lead-pipe resistance to passive movement); <span class="key-term">Akinesia/Bradykinesia</span> (slowness of movement, difficulty initiating movement, reduced facial expression [masked facies]); <span class="key-term">Postural instability</span> (impaired balance, tendency to fall). The tremor is typically asymmetric at onset and worsens with stress.</p>
        </div>
        <p>Non-motor features include depression (affects ~40% of PD patients), cognitive impairment progressing to dementia in ~30-40% of cases, REM sleep behavior disorder, anosmia (loss of smell), autonomic dysfunction (orthostatic hypotension, constipation), and psychosis (visual hallucinations, often medication-related).</p>
        <div class="clinical-note">
          <strong>Treatment:</strong>
          <p><span class="key-term">Levodopa (L-DOPA)</span> is the gold-standard treatment — it is a dopamine precursor that crosses the blood-brain barrier and is converted to dopamine. It is typically combined with carbidopa (which prevents peripheral conversion) to reduce side effects. Long-term levodopa use can produce motor fluctuations ("wearing off," "on-off" phenomena) and dyskinesias (involuntary choreiform movements). Dopamine agonists (pramipexole, ropinirole), MAO-B inhibitors, and deep brain stimulation of the subthalamic nucleus are additional treatment options.</p>
        </div>
      </div>

      <div class="content-section">
        <h2>Huntington's Disease</h2>
        <p><span class="key-term">Huntington's disease (HD)</span> is an <span class="key-term">autosomal dominant</span> neurodegenerative disorder caused by an expanded CAG trinucleotide repeat on chromosome 4, producing an abnormal huntingtin protein. The disease is 100% penetrant — anyone who inherits the gene will develop the disease if they live long enough. Typical onset is between ages 30 and 50.</p>
        <div class="definition-box">
          <strong>Pathology &amp; Clinical Features:</strong>
          <p>HD primarily affects the <span class="key-term">caudate nucleus</span> and putamen (striatum), producing progressive atrophy. The characteristic movement disorder is <span class="key-term">chorea</span> — involuntary, irregular, dance-like movements affecting the limbs, trunk, and face. The clinical triad includes: (1) choreiform movements, (2) progressive cognitive decline (subcortical dementia pattern with executive dysfunction, slowed processing), and (3) psychiatric disturbances (depression, irritability, personality changes, psychosis). Psychiatric symptoms often precede motor symptoms by years.</p>
        </div>
        <div class="example-box">
          <strong>EPPP Distinction — Parkinson's vs. Huntington's:</strong>
          <p>Parkinson's involves too little dopamine (substantia nigra degeneration) and produces hypokinetic movements (slow, reduced). Huntington's involves loss of inhibitory neurons in the striatum and produces hyperkinetic movements (excessive, involuntary chorea). Parkinson's is typically sporadic; Huntington's is autosomal dominant. Both can produce dementia, but the cognitive profiles differ: PD dementia is more posterior-cortical; HD dementia is subcortical-frontal.</p>
        </div>
        <div class="citation">The Huntington's Disease Collaborative Research Group. (1993). A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. Cell, 72(6), 971-983.</div>
      </div>

      <div class="content-section">
        <h2>Multiple Sclerosis</h2>
        <p><span class="key-term">Multiple sclerosis (MS)</span> is an autoimmune <span class="key-term">demyelinating disease</span> of the central nervous system in which the immune system attacks oligodendrocytes and the myelin sheath. This produces plaques (lesions) of demyelination scattered throughout the brain and spinal cord, disrupting saltatory conduction and producing a wide range of neurological symptoms.</p>
        <table>
          <tr><th>MS Subtype</th><th>Course</th><th>Prevalence</th></tr>
          <tr><td>Relapsing-Remitting (RRMS)</td><td>Discrete attacks (relapses) followed by partial or complete recovery; most common initial form</td><td>~85% at onset</td></tr>
          <tr><td>Secondary Progressive (SPMS)</td><td>Initially RRMS, then gradual worsening with or without relapses</td><td>~50% of RRMS convert within 10-15 years</td></tr>
          <tr><td>Primary Progressive (PPMS)</td><td>Gradual worsening from onset without distinct relapses</td><td>~10-15%</td></tr>
        </table>
        <p>Common symptoms include optic neuritis (inflammation of the optic nerve causing vision loss), sensory disturbances (numbness, tingling, Lhermitte's sign), motor weakness, spasticity, cerebellar ataxia, bladder dysfunction, fatigue, and cognitive impairment (particularly in processing speed, working memory, and executive function). Symptoms often worsen with heat (Uhthoff's phenomenon).</p>
      </div>

      <div class="content-section">
        <h2>Amyotrophic Lateral Sclerosis &amp; Other Conditions</h2>
        <h3>ALS (Lou Gehrig's Disease)</h3>
        <p><span class="key-term">Amyotrophic lateral sclerosis (ALS)</span> is a progressive motor neuron disease affecting both upper and lower motor neurons. It produces progressive muscle weakness, atrophy, fasciculations (muscle twitching), spasticity, and ultimately respiratory failure. Critically, ALS typically spares cognitive function, sensation, and eye movements until very late stages. Approximately 5-10% of cases are familial (genetic); the remainder are sporadic. Average survival is 3-5 years from symptom onset.</p>

        <h3>Wilson's Disease</h3>
        <p><span class="key-term">Wilson's disease</span> is an autosomal recessive disorder of copper metabolism causing toxic copper accumulation in the liver, brain (particularly the basal ganglia), and cornea. Neurological symptoms include tremor, dystonia, dysarthria, and psychiatric disturbances (personality changes, depression, psychosis). The pathognomonic sign is <span class="key-term">Kayser-Fleischer rings</span> — golden-brown copper deposits visible in the cornea. It is treatable with copper chelation therapy (penicillamine) and zinc supplementation if diagnosed early.</p>

        <h3>Myasthenia Gravis</h3>
        <p><span class="key-term">Myasthenia gravis</span> is an autoimmune disorder in which antibodies attack acetylcholine receptors at the neuromuscular junction, causing progressive muscle weakness that worsens with activity and improves with rest. Characteristic features include ptosis (drooping eyelids), diplopia (double vision), difficulty swallowing, and limb weakness. Treatment includes cholinesterase inhibitors (pyridostigmine), immunosuppressants, and thymectomy.</p>

        <div class="clinical-note">
          <strong>Cerebellar Disorders:</strong>
          <p>The cerebellum coordinates voluntary movement, balance, and motor learning. Cerebellar damage produces a characteristic syndrome: <span class="key-term">ataxia</span> (uncoordinated, staggering gait), <span class="key-term">dysmetria</span> (inability to accurately reach for objects — overshooting or undershooting), intention tremor (worsens as the hand approaches the target — opposite of Parkinson's resting tremor), dysarthria (slurred speech), and nystagmus (involuntary eye movements). Cerebellar signs are ipsilateral to the lesion (unlike cerebral cortex, which is contralateral).</p>
        </div>
      </div>

      <div class="content-section">
        <h2>EPPP Exam Focus Points</h2>
        <ul>
          <li><strong>Parkinson's disease</strong>: substantia nigra dopamine depletion; TRAP symptoms (tremor, rigidity, akinesia/bradykinesia, postural instability); resting tremor</li>
          <li><strong>Levodopa</strong>: gold-standard PD treatment; dopamine precursor; long-term use causes dyskinesias and motor fluctuations</li>
          <li><strong>Huntington's disease</strong>: autosomal dominant; CAG trinucleotide repeat on chromosome 4; caudate nucleus atrophy; chorea; 100% penetrance</li>
          <li><strong>Parkinson's</strong> = hypokinetic (too little movement); <strong>Huntington's</strong> = hyperkinetic (too much movement/chorea)</li>
          <li><strong>Multiple sclerosis</strong>: autoimmune CNS demyelination; relapsing-remitting is most common form; Uhthoff's phenomenon (heat worsens symptoms)</li>
          <li><strong>ALS</strong>: upper and lower motor neuron degeneration; progressive weakness; cognition typically preserved; fatal within 3-5 years</li>
          <li><strong>Wilson's disease</strong>: copper accumulation; Kayser-Fleischer rings; basal ganglia involvement; treatable</li>
          <li><strong>Myasthenia gravis</strong>: ACh receptor antibodies at neuromuscular junction; weakness worsens with activity; ptosis and diplopia</li>
          <li><strong>Cerebellar signs</strong>: ataxia, dysmetria, intention tremor, dysarthria; signs are IPSILATERAL to the lesion</li>
          <li>Intention tremor (cerebellar) worsens on reaching; resting tremor (Parkinson's) diminishes with movement</li>
        </ul>
      </div>

      <div class="nav-buttons">
        <a href="sensation-perception.html" class="nav-btn"><span><div class="nav-btn-label">Previous</div><div class="nav-btn-title">Sensation, Perception &amp; Psychophysics</div></span></a>
        <a href="cerebrovascular-injury.html" class="nav-btn"><span><div class="nav-btn-label">Next</div><div class="nav-btn-title">Cerebrovascular Disease, Brain Injury &amp; Seizures</div></span></a>
      </div>
    </main>
  </div>
  <div class="upgrade-modal-overlay" id="upgradeModal" onclick="if(event.target===this)this.classList.remove('visible')"><div class="upgrade-modal"><div class="upgrade-modal-icon"><svg width="28" height="28" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2"><polygon points="12 2 15.09 8.26 22 9.27 17 14.14 18.18 21.02 12 17.77 5.82 21.02 7 14.14 2 9.27 8.91 8.26 12 2"/></svg></div><h3>Upgrade to Unlock</h3><p>Flashcards, Quick Quizzes, and Mastery Quizzes are available on paid plans. Upgrade today to test your knowledge and track your progress.</p><div class="upgrade-modal-actions"><button class="btn-dismiss" onclick="document.getElementById('upgradeModal').classList.remove('visible')">Maybe Later</button><a href="../../index.html" class="btn-upgrade">View Plans</a></div></div></div>
  <script>function chapterAction(action, domainNum) { var tier = 'free'; try { var s = sessionStorage.getItem('passeppp_session'); if (s) { tier = JSON.parse(s).tier || 'free'; } } catch(e) {} if (tier === 'free') { document.getElementById('upgradeModal').classList.add('visible'); return; } if (action === 'flashcards') window.location.href = '../../index.html'; else if (action === 'quiz-fundamental') window.location.href = '../../index.html'; else if (action === 'advanced-learning') { var ch = document.querySelector('h1').textContent.trim(); window.location.href = '../../index.html'; } }</script>
</body>
</html>
